Clinical and molecular characteristics of neonatal Klebsiella pneumoniae sepsis

Hebei Provincial Neonatal Sepsis Research Collaboration Group

Chinese Journal of Contemporary Pediatrics ›› 2026, Vol. 28 ›› Issue (3) : 269-276.

PDF(863 KB)
HTML
PDF(863 KB)
HTML
Chinese Journal of Contemporary Pediatrics ›› 2026, Vol. 28 ›› Issue (3) : 269-276. DOI: 10.7499/j.issn.1008-8830.2507029
CLINICAL RESEARCH

Clinical and molecular characteristics of neonatal Klebsiella pneumoniae sepsis

Author information +
History +

Abstract

Objective To characterize the molecular profiles of Klebsiella pneumoniae isolates causing neonatal sepsis and assess their clinical implications. Methods Clinical data and bloodstream isolates from neonates with Klebsiella pneumoniae sepsis admitted to four hospitals in Hebei Province from 2020 to 2024 were collected. Whole-genome sequencing was performed to analyze molecular characteristics of the pathogenic strains. Clinical features were compared between virulence gene-carrying and non-carrying groups. A phylogenetic tree based on sequencing data was constructed to explore potential transmission routes. Results A total of 37 infants and their clinical bloodstream isolates were included. Thirty-three (89%) had late-onset infection, and 32 (86%) were hospital-acquired. Preterm infants accounted for 95%. Twenty-eight (76%) underwent invasive procedures, and 13 (35%) had prior exposure to broad-spectrum antimicrobials. All infants were cured after treatment. Resistance rates to third-generation cephalosporins and carbapenems were 89% and 27%, respectively. ST45 was the most common sequence type. The carriage rates of extended-spectrum β-lactamase and carbapenemase genes were 84% and 24%, respectively. Concordance between resistance genes and phenotypic resistance was 86%. Clinical antimicrobial use was not fully consistent with resistance phenotypes or gene carriage. Among virulence genes, ybt had the highest carriage rate (54%). The proportion of concurrent infections at other sites did not differ significantly between the virulence gene-carrying and non-carrying groups (50% vs 29%, P=0.315). Phylogenetic analysis revealed intra-hospital and inter-hospital transmission of Klebsiella pneumoniae strains causing neonatal sepsis. Conclusions Detection of antimicrobial resistance and virulence genes facilitates deeper understanding of bacterial pathogenesis and provides a basis for optimizing regional infection control and antimicrobial treatment strategies.

Key words

Neonatal sepsis / Klebsiella pneumoniae / Whole-genome sequencing / Multidrug resistance

Cite this article

Download Citations
Hebei Provincial Neonatal Sepsis Research Collaboration Group. Clinical and molecular characteristics of neonatal Klebsiella pneumoniae sepsis[J]. Chinese Journal of Contemporary Pediatrics. 2026, 28(3): 269-276 https://doi.org/10.7499/j.issn.1008-8830.2507029

References

[1]
全国细菌耐药监测网. 2023年全国细菌耐药监测报告(简要版)[EB/OL]. (2024-11-18)[2025-04-12].
[2]
World Health Organization. WHO bacterial priority pathogens list, 2024: bacterial pathogens of public health importance to guide research, development and strategies to prevent and control antimicrobial resistance[EB/OL]. (2024-05-17)[2025-04-20].
[3]
Navon-Venezia S, Kondratyeva K, Carattoli A. Klebsiella pneumoniae: a major worldwide source and shuttle for antibiotic resistance[J]. FEMS Microbiol Rev, 2017, 41(3): 252-275. DOI: 10.1093/femsre/fux013 .
[4]
Choby JE, Howard-Anderson J, Weiss DS. Hypervirulent Klebsiella pneumoniae: clinical and molecular perspectives[J]. J Intern Med, 2020, 287(3): 283-300. PMCID: PMC7057273. DOI: 10.1111/joim.13007 .
[5]
Russo TA, Marr CM. Hypervirulent Klebsiella pneumoniae [J]. Clin Microbiol Rev, 2019, 32(3): e00001-19. PMCID: PMC6589860. DOI: 10.1128/CMR.00001-19 .
[6]
Han X, Yao J, He J, et al. Clinical and laboratory insights into the threat of hypervirulent Klebsiella pneumoniae [J]. Int J Antimicrob Agents, 2024, 64(3): 107275. DOI: 10.1016/j.ijantimicag.2024.107275 .
[7]
Namikawa H, Oinuma KI, Kaneko Y, et al. Antimicrobial resistance in hypermucoviscous and non-hypermucoviscous Klebsiella pneumoniae: a systematic review and meta-analysis[J]. Emerg Microbes Infect, 2025, 14(1): 2438657. PMCID: PMC11650459. DOI: 10.1080/22221751.2024.2438657 .
[8]
Investigators of the Delhi Neonatal Infection Study (DeNIS) Collaboration. Characterisation and antimicrobial resistance of sepsis pathogens in neonates born in tertiary care centres in Delhi, India: a cohort study[J]. Lancet Glob Health, 2016, 4(10): e752-e760. DOI: 10.1016/S2214-109X(16)30148-6 .
[9]
河北新生儿败血症研究协作组. 中国河北省新生儿败血症病原体构成及耐药性的横断面研究[J]. 中国当代儿科杂志, 2024, 26(4): 350-357. PMCID: PMC11057296. DOI: 10.7499/j.issn.1008-8830.2309107 .
[10]
中华医学会儿科学分会新生儿学组, 中华儿科杂志编辑委员会. 新生儿败血症诊断与治疗专家共识(2024)[J]. 中华儿科杂志, 2024, 62(10): 931-940. DOI: 10.3760/cma.j.cn112140-20240505-00307 .
[11]
中华人民共和国国家卫生和计划生育委员会. 临床微生物实验室血培养操作规范: WS/T 503-2017 [S]. 北京: 中国标准出版社, 2017.
[12]
CLSI. Performance standards for antimicrobial susceptibility testing: M100 31st edition [S]. Malvern, PA, USA: CLSI, 2021.
[13]
Lam MMC, Wick RR, Watts SC, et al. A genomic surveillance framework and genotyping tool for Klebsiella pneumoniae and its related species complex[J]. Nat Commun, 2021, 12(1): 4188. PMCID: PMC8263825. DOI: 10.1038/s41467-021-24448-3 .
[14]
Wyres KL, Wick RR, Gorrie C, et al. Identification of Klebsiella capsule synthesis loci from whole genome data[J]. Microb Genom, 2016, 2(12): e000102. PMCID: PMC5359410. DOI: 10.1099/mgen.0.000102 .
[15]
Seemann T. Prokka: rapid prokaryotic genome annotation[J]. Bioinformatics, 2014, 30(14): 2068-2069. DOI: 10.1093/bioinformatics/btu153 .
[16]
Page AJ, Cummins CA, Hunt M, et al. Roary: rapid large-scale prokaryote pan genome analysis[J]. Bioinformatics, 2015, 31(22): 3691-3693. PMCID: PMC4817141. DOI: 10.1093/bioinformatics/btv421 .
[17]
Rozewicki J, Li S, Amada KM, et al. MAFFT-DASH: integrated protein sequence and structural alignment[J]. Nucleic Acids Res, 2019, 47(W1): W5-W10. PMCID: PMC6602451. DOI: 10.1093/nar/gkz342 .
[18]
Price MN, Dehal PS, Arkin AP. FastTree 2--approximately maximum-likelihood trees for large alignments[J]. PLoS One, 2010, 5(3): e9490. PMCID: PMC2835736. DOI: 10.1371/journal.pone.0009490 .
[19]
Wei X, Liang J, Zhang H, et al. Clinical features and risk factors of Klebsiella pneumoniae infection in premature infants: a retrospective cohort study[J]. BMC Infect Dis, 2024, 24(1): 1311. PMCID: PMC11569604. DOI: 10.1186/s12879-024-10201-w .
[20]
Zhang Y, Guo LY, Song WQ, et al. Risk factors for carbapenem-resistant K. pneumoniae bloodstream infection and predictors of mortality in Chinese paediatric patients[J]. BMC Infect Dis, 2018, 18(1): 248. PMCID: PMC5984460. DOI: 10.1186/s12879-018-3160-3 .
[21]
Chen X, Shi Y. Determinants of microbial colonization in the premature gut[J]. Mol Med, 2023, 29(1): 90. PMCID: PMC10324143. DOI: 10.1186/s10020-023-00689-4 .
[22]
Du Q, Xu Q, Pan F, et al. Association between intestinal colonization and extraintestinal infection with carbapenem-resistant Klebsiella pneumoniae in children[J]. Microbiol Spectr, 2023, 11(2): e0408822. PMCID: PMC10100809. DOI: 10.1128/spectrum.04088-22 .
[23]
Wang Q, Wang R, Wang S, et al. Expansion and transmission dynamics of high risk carbapenem-resistant Klebsiella pneumoniae subclones in China: an epidemiological, spatial, genomic analysis[J]. Drug Resist Updat, 2024, 74: 101083. DOI: 10.1016/j.drup.2024.101083 .
[24]
Hu Y, Yang Y, Feng Y, et al. Prevalence and clonal diversity of carbapenem-resistant Klebsiella pneumoniae causing neonatal infections: a systematic review of 128 articles across 30 countries[J]. PLoS Med, 2023, 20(6): e1004233. PMCID: PMC10281588. DOI: 10.1371/journal.pmed.1004233 .
[25]
Su M, Satola SW, Read TD. Genome-based prediction of bacterial antibiotic resistance[J]. J Clin Microbiol, 2019, 57(3): e01405-e01418. PMCID: PMC6425178. DOI: 10.1128/JCM.01405-18 .
[26]
Alvi RF, Aslam B, Rasool MH, et al. Transcriptional response of multidrug-resistant Klebsiella pneumoniae clinical isolates to ciprofloxacin stress[J]. Can J Infect Dis Med Microbiol, 2021, 2021: 5570963. PMCID: PMC8645360. DOI: 10.1155/2021/5570963 .
[27]
史梦兰, 李文茹, 谢小保. 临床肺炎克雷伯菌的异质性耐药研究进展[J]. 微生物学通报, 2024, 51(7): 2326-2336. DOI: 10.13344/j.microbiol.china.230482 .
[28]
Pu D, Zhao J, Chang K, et al. "Superbugs" with hypervirulence and carbapenem resistance in Klebsiella pneumoniae: the rise of such emerging nosocomial pathogens in China[J]. Sci Bull (Beijing), 2023, 68(21): 2658-2670. DOI: 10.1016/j.scib.2023.09.040 .
[29]
Lin TL, Lee CZ, Hsieh PF, et al. Characterization of integrative and conjugative element ICEKp1-associated genomic heterogeneity in a Klebsiella pneumoniae strain isolated from a primary liver abscess[J]. J Bacteriol, 2008, 190(2): 515-526. PMCID: PMC2223707. DOI: 10.1128/JB.01219-07 .
[30]
Lam MMC, Wick RR, Wyres KL, et al. Genetic diversity, mobilisation and spread of the yersiniabactin-encoding mobile element ICEKp in Klebsiella pneumoniae populations[J]. Microb Genom, 2018, 4(9): e000196. PMCID: PMC6202445. DOI: 10.1099/mgen.0.000196 .
[31]
中国老年医学学会检验医学分会, 上海市医学会检验医学专科分会, 上海市微生物学会临床微生物学专业委员会. 高毒力肺炎克雷伯菌实验室检测专家共识[J]. 中华检验医学杂志, 2023, 46(11): 1164-1172. DOI: 10.3760/cma.j.cn114452-20230925-00162 .
[32]
Zhang Y, Jin L, Ouyang P, et al. Evolution of hypervirulence in carbapenem-resistant Klebsiella pneumoniae in China: a multicentre, molecular epidemiological analysis[J]. J Antimicrob Chemother, 2020, 75(2): 327-336. DOI: 10.1093/jac/dkz446 .
[33]
Zhou K, Xiao T, David S, et al. Novel subclone of carbapenem-resistant Klebsiella pneumoniae sequence type 11 with enhanced virulence and transmissibility, China[J]. Emerg Infect Dis, 2020, 26(2): 289-297. PMCID: PMC6986851. DOI: 10.3201/eid2602.190594 .
[34]
Dong N, Sun Q, Huang Y, et al. Evolution of carbapenem-resistant serotype K1 hypervirulent Klebsiella pneumoniae by acquisition of bla VIM-1-bearing plasmid[J]. Antimicrob Agents Chemother, 2019, 63(9): e01056-19. PMCID: PMC6709456. DOI: 10.1128/AAC.01056-19 .
[35]
Xu Y, Zhang J, Wang M, et al. Mobilization of the nonconjugative virulence plasmid from hypervirulent Klebsiella pneumoniae [J]. Genome Med, 2021, 13(1): 119. PMCID: PMC8299605. DOI: 10.1186/s13073-021-00936-5 .
[36]
Mukherjee S, Mitra S, Dutta S, et al. Neonatal sepsis: the impact of carbapenem-resistant and hypervirulent Klebsiella pneumoniae [J]. Front Med (Lausanne), 2021, 8: 634349. PMCID: PMC8225938. DOI: 10.3389/fmed.2021.634349 .
[37]
Liao W, Liu Y, Zhang W. Virulence evolution, molecular mechanisms of resistance and prevalence of ST11 carbapenem-resistant Klebsiella pneumoniae in China: a review over the last 10 years[J]. J Glob Antimicrob Resist, 2020, 23: 174-180. DOI: 10.1016/j.jgar.2020.09.004 .
[38]
Luo K, Tang J, Qu Y, et al. Nosocomial infection by Klebsiella pneumoniae among neonates: a molecular epidemiological study[J]. J Hosp Infect, 2021, 108: 174-180. DOI: 10.1016/j.jhin.2020.11.028 .
[39]
Guo L, Wang L, Zhao Q, et al. Genomic analysis of KPC-2-producing Klebsiella pneumoniae ST11 isolates at the respiratory department of a tertiary care hospital in Beijing, China[J]. Front Microbiol, 2022, 13: 929826. PMCID: PMC9244631. DOI: 10.3389/fmicb.2022.929826 .
[40]
Yan Z, Ju X, Zhang Y, et al. Analysis of the transmission chain of carbapenem-resistant Enterobacter cloacae complex infections in clinical, intestinal and healthcare settings in Zhejiang province, China (2022-2023)[J]. Sci Total Environ, 2024, 920: 170635. DOI: 10.1016/j.scitotenv.2024.170635 .

Footnotes

所有作者声明无利益冲突。

PDF(863 KB)
HTML

Accesses

Citation

Detail

Sections
Recommended

/